A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects with Erythropoietic Protoporphyria

    Project: Other project

    Project Details

    StatusActive
    Effective start/end date6/6/186/5/23